| 7:55 AM | Welcome & Introduction | Renu Virmani, MD (Speaker) Robert L. Wilensky, MD (Speaker)
|
| 8:00 AM | Clinical Need for Determination of Vulnerable Plaques | Robert L. Wilensky, MD (Speaker)
|
| 8:10 AM | New Insights in the Pathophysiology of Vulnerable Plaque and Patients | Renu Virmani, MD (Moderator) Robert L. Wilensky, MD (Moderator)
|
| 8:10 AM | Development of the Necrotic Core | Renu Virmani, MD (Speaker)
|
| 8:20 AM | Necrotic Core Area, Fibrous Cap Thickness and VP Development | Roderic I. Pettigrew, MD, PhD (Speaker)
|
| 8:30 AM | Role of Inflammation and Immune Responses | Robert L. Wilensky, MD (Speaker)
|
| 8:40 AM | Role of Focal Calcifications | Pedro R. Moreno, MD (Speaker)
|
| 8:50 AM | The Emerging Role of the Vasa Vasorum and Intraplaque Hemorrhage Haptoglobin | Pedro R. Moreno, MD (Speaker)
|
| 9:00 AM | Role of Intraplaque Hemorrhage in the Development of VP | Renu Virmani, MD (Speaker)
|
| 9:10 AM | Role of Apoptosis in the Development of VP | Pedro R. Moreno, MD (Speaker)
|
| 9:20 AM | Preclinical Models to Assess Vulnerable Plaque | Juan F. Granada, MD (Speaker)
|
| 9:30 AM | Panel Discussion | Juan F. Granada, MD (Panelist) Pedro R. Moreno, MD (Panelist) Roderic I. Pettigrew, MD, PhD (Panelist) Renu Virmani, MD (Panelist) Robert L. Wilensky, MD (Moderator)
|
| 10:05 AM | Coffee Break |
|
| 10:20 AM | Non-invasive Imaging (Clinical Studies) | Giuseppe Biondi Zoccai, MD (Moderator) Stephen E. Epstein, MD (Moderator)
|
| 10:20 AM | Cardiac Imaging of High-risk Plaques | Valentin Fuster, MD, PhD (Speaker)
|
| 10:30 AM | The Future of Non-evasive Molecular Methods for Identification of Patients | Stephen E. Epstein, MD (Speaker)
|
| 10:40 AM | MRI Imaging of High-risk Plaques | Renu Virmani, MD (Speaker)
|
| 10:50 AM | FDG/PET Imaging of High-risk Plaques | Valentin Fuster, MD, PhD (Speaker)
|
| 11:00 AM | Carotid IMT: A Relevant Marker? | Allen J. Taylor, MD (Speaker)
|
| 11:10 AM | Panel Discussion | Giuseppe Biondi Zoccai, MD (Panelist) Stephen E. Epstein, MD (Moderator) Valentin Fuster, MD, PhD (Panelist) Allen J. Taylor, MD (Panelist)
|
| 12:00 PM | Lunch & Visit the Exhibits |
|
| 1:00 PM | Relevant Biomarkers of Plaque Instability | Robert S. Schwartz, MD (Speaker)
|
| 1:10 PM | Vulnerable Blood | Jeffrey S. Berger, MD (Speaker)
|
| 1:20 PM | Invasive Imaging of Vulnerable Plaques I | Eveline S. Regar, MD, PhD (Moderator) Sergio Waxman, MD (Moderator)
|
| 1:20 PM | OCT and Vasa Vasorum | Eveline S. Regar, MD, PhD (Speaker)
|
| 1:30 PM | Use of Angioscopy to Localize Vulnerable Plaques | Yasunori Ueda, MD, PhD (Speaker)
|
| 1:40 PM | OCT and Stent Thrombosis | Eveline S. Regar, MD, PhD (Speaker)
|
| 1:50 PM | Can OCT Image Cells in vivo? | Marc D Feldman, MD (Speaker)
|
| 2:00 PM | OCT & Vulnerable Plaque: Natural History Studies | Sergio Waxman, MD (Speaker)
|
| 2:10 PM | Discussion | Marc D Feldman, MD (Panelist) Juan F. Granada, MD (Panelist) Eveline S. Regar, MD, PhD (Moderator) Yasunori Ueda, MD, PhD (Panelist) Sergio Waxman, MD (Panelist)
|
| 2:55 PM | Refreshment Break |
|
| 3:10 PM | Invasive Imaging of Vulnerable Plaques II | Sergio Waxman, MD (Moderator) Robert L. Wilensky, MD (Moderator)
|
| 3:10 PM | IVUS and NIRs in DM/HC Pigs | Robert L. Wilensky, MD (Speaker)
|
| 3:20 PM | Near Infrared Spectroscopy (NIRS) Technology Update | James E. Muller, MD (Speaker)
|
| 3:30 PM | Near Infrared Spectroscopy Case Studies and Clinical Relevance | Sergio Waxman, MD (Speaker)
|
| 3:40 PM | Combined NIRS and IVUS: Clinical Results | Eveline S. Regar, MD, PhD (Speaker)
|
| 3:50 PM | New Virtual Histology Findings | Paulina Margolis, Other (Speaker)
|
| 4:00 PM | How Plaque Morphology Assessment Should Guide PCI | Sergio Waxman, MD (Speaker)
|
| 4:10 PM | Discussion | Paulina Margolis, Other (Panelist) James E. Muller, MD (Panelist) Eveline S. Regar, MD, PhD (Panelist) Sergio Waxman, MD (Moderator) Robert L. Wilensky, MD (Moderator)
|
| 4:40 PM | Clinical Trials | H. Bryan Brewer, MD (Moderator) Ron Waksman, MD (Moderator)
|
| 4:40 PM | Endothelial Shear Stress Update on PREDICTION and CORE 320 Trials | Peter H. Stone, MD (Speaker)
|
| 4:50 PM | Lessons from the IBIS Trials | Eveline S. Regar, MD, PhD (Speaker)
|
| 5:05 PM | Take Home Message from PROSPECT | Gregg W. Stone, MD (Speaker)
|
| 5:15 PM | Delipidation for ACS Patients | Ron Waksman, MD (Speaker)
|
| 5:25 PM | Self-expanding Stent for Plaque Lesion Sealing Update on the SECRITT Trial | Eveline S. Regar, MD, PhD (Speaker)
|
| 5:35 PM | Will DES be an Option for Sealing Vulnerable Plaques? | Renu Virmani, MD (Speaker)
|
| 5:45 PM | Discussion | H. Bryan Brewer, MD (Moderator) Eveline S. Regar, MD, PhD (Panelist) Gregg W. Stone, MD (Panelist) Peter H. Stone, MD (Panelist) Renu Virmani, MD (Panelist) Ron Waksman, MD (Moderator)
|
| 6:00 PM | Adjourn |
|